← Back to Calendar
Live Company Data
NGM
Updated
just now
· Data: FMP
Current Price
$14.94
+572.97%
+$12.72 today
Day: $14.51 – $15.42
Market Cap
N/A
Shares out: 178.73M
Float: 93.67M
52-Week Range
Current price is at 96% of 52-week range
Sector
Healthcare
Biotechnology
⚠️ Financial data is for informational purposes only. Not investment advice. Prices may be delayed.
Indication
Q4 2025 earnings + zovegalisib SERENA-PI3K update
Key Notes
Q4 2025 earnings reported February 26, 2026. Cash: ~$555M at end of Q4 2025. RLY-2608 renamed to zovegalisib following Breakthrough Therapy designation. Initial Phase 1/2 data at ESMO TAT March 16, 2026. Full SERENA-PI3K Phase 2 readout expected H1 2026 (ASCO). Breast cancer triplet data and Phase 3 plans expected 2026.
⚠️ Not Investment Advice: This information is provided for educational purposes only.
PDUFA dates are FDA target action dates, not guaranteed approval dates. The FDA may extend the review period,
issue Complete Response Letters, or take unexpected actions. Probability of approval scores are based on
historical base rates and do not account for drug-specific factors. Always consult a financial advisor
before making investment decisions.
Discussion
Share your analysis, research, or questions about this catalyst. No account required.